Troxevasin neo (Troxerutin, Heparin sodium, Dexpanthenol) gel
21830USD

Troxevasin neo (Troxerutin, Heparin sodium, Dexpanthenol) gel

SKU:2079
To favorites
Troxevasin neo (Troxerutin, Heparin sodium, Dexpanthenol) anticoagulant agent of direct action for local use, has a venotonic, venoprotective, anti-edematous, anti-inflammatory, anticoagulant and antioxidant effect, increases the tone of capillaries, contributes to the normalization of microcirculation and tissue trophism, reduces congestion
Active substance:Troxerutin, Heparin sodium, Dexpanthenol
Pharmacological group:Antithrombotic
Formulation:Gel
Country of origin:Bulgaria
In stock
$18
11
Description
Features
Reviews

Instructions for Troxevasin neo (Troxerutin, Heparin sodium, Dexpanthenol) gel

English product name
Troxevasin® NEO

Release form
Outdoor gel

Description:

Gel for external application from yellowish to greenish-yellow color, transparent or almost transparent.

1g
sodium heparin 1.7 mg (300 ME)
troxerutin 20 mg
dexpantenol 50 mg
Auxiliary substances: carbomer - 7 mg, propylene glycol - 100 mg, methylparahydroxybenzoate - 0.8 mg, propyl parahydroxybenzoate - 0.2 mg, trolamine - 4.2 mg, water purified - up to 1 g.

40 g - aluminium tubes (1) - cardboard packs.
40 g - laminate tubes (1) - cardboard packs.
100 g - laminate tubes (1) - cardboard packs.

ATC codes
C05BA53 Heparin in combination with other drugs

Clinical-pharmacological groups / Group affiliation
The preparation has antithrombotic, angioprotective, venotonizing and tissue regeneration enhancing effects for external use

Active substance Troxevasin

  • dexpantenol
  • sodium heparin
  • troxerutin

Pharmacotherapy group:

Direct-acting anticoagulant agent for local use+other preparations

Storage Conditions
The drug should be stored in a place inaccessible to children at a temperature not higher than 25 ° C.

Best before date
The shelf life is two years.

Testimony Troxevasin:

  • varicose disease;
  • chronic venous insufficiency with symptoms such as swelling and pains in the legs, feeling of heaviness, tightness, fatigue of the legs, vascular sprockets and meshes, seizures, paresthesia;
  • thrombophlebitis;
  • periphlebitis;
  • varicose dermatitis;
  • Pain and swelling of a traumatic nature (for bruising, stretching, injuries).

Method of use, course and dosage Troxevasin:

It is used externally. The gel is applied in a thin layer to the area of the lesion twice a day in the morning and in the evening, spreading evenly over the surface of the skin with light rubbing movements until completely absorbed. If necessary, the gel can be applied under bandages or elastic stockings.

The success of drug treatment depends to a large extent on its regular use for a long time. Treatment is two to three weeks. The need for longer treatment is determined by the attending doctor.
It is recommended to repeat the course of treatment two to three times a year.
It is recommended to combine with Troxevazine® capsules to enhance the effect.

Terms of Sale
No prescription.

Use in children
Contraindicated for children and adolescents under 18 years of age (no experience of use).

  • Nosology Troxevasin (ICD codes)
  • I80
  • Phlebitis and thrombophlebitis
  • I83
  • Varicose veins of lower limbs
  • I87.2
  • Venous insufficiency (chronic) (peripheral)
  • T14.0
  • Superficial injury of an unspecified area of the body (including abrasion, bruising, bruising, hematoma, bite of a non-venomous insect)
  • T14.3
  • Dislocation, stretching and overtension of the capsule-bonding apparatus of the unspecified body region joint

Pharmacological effect Troxevasin:

A combined preparation for external use. The action is due to its ingredients.
Troxerutin is an angioprotective agent. Has P-vitamin activity: It has venotonizing, venoprotective, anti-edema, anti-inflammatory, anti-Venting and antioxidant effects. Reduces permeability and brittleness of capillaries, increases their tonus. Increases the density of the vascular wall. Promotes the normalization of microcirculation and tissue trophic, reduces the stagnation phenomena

Features
Active substance
Pharmacological group
Formulation
Country of origin
Brand
Expiration Date
No reviews yet — your comment may be first.
All reviews 0
general rating